The expression of CHI3L1 is increased in patients with various neurological diseases, including Alzheimer’s disease (AD), amyotrophic lateral sclerosis, multiple sclerosis, and schizophrenia (SCZ)71. Here, CHI3L1 is linked to amyotrophic lateral sclerosis.